The prevalence of IgG, IgA and IgE antibodies against various SARS-CoV-2 antigens was analyzed in serum samples collected from 73 COVID-19 patients > 14 DPS (Table 2), when the majority of patients were expected to be seroconverted. The gene discussed is IGHE; the disease is COVID-19.